.Pharmacolibrary.Drugs.C_CardiovascularSystem.C07A_BetaBlockingAgents.C07AA12_Nadolol.Nadolol

Information

Nadolol is a non-selective beta-adrenergic receptor blocker used primarily for the management of hypertension and angina pectoris. It is also sometimes used off-label for migraine prophylaxis and certain types of arrhythmia. It is FDA approved and is in clinical use today.

Pharmacokinetics

Pharmacokinetic parameters reported in healthy adult volunteers after single oral administration under fasting conditions.

References

1. McGillis, E, et al., & LeRoy, J (2020). Death Associated With Nadolol for Infantile Hemangioma: A Case for Improving Safety. Pediatrics 145(1) –. DOI:10.1542/peds.2019-1035 PUBMED:https://pubmed.ncbi.nlm.nih.gov/31852735

Revisions

• 06/2025 initial generated model